arrow
S

Sunita Ghosh

university of alberta
H指数:49
被引数:1.2万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The effects of a powdered meal replacement intake on inflammation, gut microbiota, and metabolism compared to habitual diet in people with excess body weight – results from a randomized controlled trial

与习惯性饮食相比,粉末状代餐摄入对超重人群炎症、肠道微生物群和代谢的影响——来自一项随机对照试验的结果

2026-05-150
PRE
A 107 Gene Nanostring Assay Effectively Translates the Cancer Genome Atlas, and Tumour Microenvironment Gastric Cancer Molecular Classification to a Patient-Derived Organoid Model

107 Gene Nanostring Assay 有效地将癌症基因组图谱和肿瘤微环境胃癌分子分类转化为患者来源的类器官模型

2025-11-121
OAAI
The effects of docosahexaenoic acid (DHA) on plasma cytokines, oxylipins, and tumor-infiltrating lymphocytes from women with breast cancer undergoing neoadjuvant chemotherapy in the DHA-WIN trial

DHA(二十二碳六烯酸)对DHA-WIN试验中接受新辅助化疗的乳腺癌女性患者血浆细胞因子、氧化脂质和肿瘤浸润淋巴细胞的影响

2025-07-100
PRE
Corrigendum to “Decreased ATM Protein Expression Is Substantiated with PTEN Loss in Defining Aggressive Phenotype of Prostate Cancer Associated with Lethal Disease” [Eur. Urol. Open Sci. 29 (2021) 93-101]

勘误:“ATM蛋白表达降低与PTEN缺失共同定义了与致死性疾病相关的侵袭性前列腺癌表型” [Eur. Urol. Open Sci. 29 (2021) 93-101]

2025-06-110
OA
Safety and efficacy of docosahexaenoic acid supplementation during neoadjuvant breast cancer therapy: Findings from the phase II, double-blind, randomized controlled DHA-WIN trial

二十二碳六烯酸补充剂在辅助性乳腺癌治疗期间的安全性与有效性:DHA-WIN II期双盲随机对照试验的结果

2025-06-090
OA
Docosahexaenoic acid (DHA) supplementation attenuates changes in the concentration, phenotype, and response of immune peripheral blood cells in breast cancer patients undergoing neoadjuvant therapy. Secondary findings from the DHA-WIN trial

二十二碳六烯酸(DHA)补充剂可减轻接受新辅助治疗的乳腺癌患者外周血免疫细胞在浓度、表型及反应性方面的变化。DHA-WIN试验的次要发现

2025-05-220
OA
Exploratory outcomes of the DHA WIN randomized controlled trial: Supplementing women with docosahexaenoic acid did not reduce the impact of neoadjuvant breast cancer chemotherapy on quality of life or exercise behaviour

DHA WIN随机对照试验的探索性结果:为女性补充docosahexaenoic acid并未减轻新辅助乳腺癌化疗对生活质量或运动行为的影响

2025-05-020
OA